Manas Petroleum Corporation (OTC:MNAP) got the up move again. Yesterday, the stock soared almost 10% and its traded volume rose up at once. The strangest thing here is that the gain happened unexpectedly and at no news released. Though, it looks like something is going on with Manas, which will be soon revealed.

The last news by the company came up in the beginning of this month, when it announced a proposed public offering of common shares and reported its financials. However, the offering was a subject to certain conditions and Manas was hoping to close it in late March or early April this year. The news being announced, no further information on the matter has been published yet, and no one is familiar with the company’s current operations.

According to traders’ discussion on the investorshub.com message board, it is expected the up move of MNAP to continue as news of some drilling was approaching. However, no news has been released at this point. Still, this rumor has probably pumped up MNAP stock price to some extent, and now investors are curious to know how far it may go.

Another interesting fact about Manas was that last week Mr. Heinz Scholz, a director and 10% owner of the company, has disposed certain amount of its common stock with no reasonable explanation. Was it a hard effort for a gain or not, is still unanswered question though.[BANNER]

Manas Petroleum is an international oil and gas company with primary focus on exploration and development in South-Eastern Europe, Central Asia and Mongolia. Last month, MNAP hit another impressive gain on some investors’ suggestions, however, it didn’t last long. Meanwhile, the only problem of Manas remains the same – financials.

The company’s quarterly report shows no revenues, however, there are significant losses uncovered. Based on the business plan for the next 12 months, the management of Manas claims that the company will need about $8,2 million to fund its operations, though it doesn’t expect to need the additional funding before Oct 2011. At the same time, in order to continue operations beyond October, the team will still require further funds, “raised through additional equity and/or debt financing”. This, however, may be dilutive to the shareholders.

Read this article:

Read the original:
Should You Invest in Frontier Markets?

We all know how this market works, or most of us do, and sometimes you just have to laugh when you read some of these press releases. Today’s CCAA release ranks right up there with one of the fluffiest I have seen in quite some time. To say there is a $1 TRILLION dollar demand for anything is quite a statement.

View post:
CCAA – Laugh Of The Day – Where Do You Get This $1 TRILLION Number From?

It looks like the shares of Genmed Holdings Corp. (OTC:GENM) will have a hot week at hand. A paid promotional campaign for the stock began today, giving the shares an exceptional opportunity to repair their long-term oversold status and lack of any trading interest.

A stock promoter has sent today e-mail alerts to his subscribers, presenting the company as an established producer of generic medicine in Europe and as holding enormous potential due to its distribution licenses and competitive advantages. Unfortunately, it seems like it wasn’t love at first sight. For the paean of praise the promoter got a compensation of $75,000 in cash paid by a third party and the marketing campaign will run for five days starting today.

GENM stock looks like it could use some help in any case. The stock is highly illiquid and got the considerable volume of over 38,000 shares just in the last trading session on Friday. That volume did not move the price an inch upwards and the stock closed as usually at $0.37 for a share. Low liquidity and some bullish technical parameters could suggest that any additional demand could easily push GENM share price up without any concerns. However, even if GENM explodes today it is unlikely to stay up for long as the fundamentals of the company show that even the current stock price is by far too high.

Lastly the shares have been traded at an over 11,000 multiple to the company’s sales, the industry average being only about 8. Genmed’s business has negative tangible worth, and all the potential hiding in the “medical registration rights” valued at $5.6 million might take time and cost shareholder dilution until it gets realized.

Genmed’s latest 10-Q reveals meager revenues coming from consulting services, not from product sales, and the lower production and distribution costs stated as a competitive advantage in the promoter’s alert are also only positive projections. The management is still in the process of negotiating distribution agreements and sufficient cash to cover the short-term needs is also not available.

See more here:

Although BioPack Environmental Solutions, Inc. (OTC:BPAC) intend to sell out substantially all of their assets in order to survive and the their stock has lost 80% of its value since the last time it was promoted, yesterday BPAC share price surged up. Again, powered by aggressive stock promotions.

Yesterday, BPAC has gained a lot of buying pressure already before the market opened, and entered the session with a gap up. The share price closed then at $0.17, 21.43% higher than the previous day, and this time the promoters achieved an even higher trading volume for the illiquid stock than their forerunners did in the middle of this January. After the peaks reached by the share price at that time, the stock has been climbing down all the year round, but things changed these days.

According to the promotional disclosures, two third parties have financed the second for this year promotional wave, the trading alerts being started already on Monday. At least $65,000 have been spent on the favorable coverage of BPAC, leading to 4.07 million share turnover during the day, a value 58 times the average trading volume of the shares.

At the same time, the latest financial results of BioPack Environmental and especially their latest SEC filing from last Thursday, could hardly suggest that such a run-up on the shares could take place. The company invited its shareholders to a special meeting, on which they will be asked to approve the sale of substantially all the assets the company has. For sale are all the shares of the BioPack subsidiaries, which are responsible for all BPAC manufacturing facilities and equipment in China. According to the filed document, without that sale the company is unlikely to continue as a going concern, and after the sale management plans to concentrate solely on the promoting and selling of the biodegradable food container and packaging products.

A purchaser has also been found: a company incorporated in the Virgin Islands. Together with buying all the manufacturing equipment, the purchaser has also agreed on a distribution contract, which grants BioPack the right to sell their products in Europe, North America, Australia, Africa, South America and Hong Kong for a period of 12 months.

Read the original:

Read more:
Where to Invest during a Slow Recovery? U.S. or Emerging Markets?

Continued here:
It’s 1998 & You’re handed $100K to Invest